Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The main objective of this study is to assess the effect of spironolactone on interstitial fibrosis in kidney transplant recipients receiving calcineurin inhibitors
Epistemonikos ID: b7bd00aa0dfd9b6c3bbea03aed8f0e95ecd2e166
First added on: May 05, 2024